Streetbeat News

Price Targets

TNDM

Wells Fargo analyst Larry Biegelsen maintains an Overweight rating on Tandem Diabetes Care (TNDM) and raises the price target from $45 to $50.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 6:06 pm

ZYME

Wells Fargo analyst Derek Archila has maintained an Overweight rating on Zymeworks (NASDAQ:ZYME) but lowered the price target from $14 to $12.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 6:04 pm

ASND

Wells Fargo analyst Derek Archila has maintained an Overweight rating on Ascendis Pharma (NASDAQ:ASND) and increased the price target from $260 to $262.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 6:03 pm

WCC

Keybanc analyst Ken Newman maintains an Overweight rating on WESCO Intl (NYSE:WCC) and raises the price target from $190 to $205.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 6:02 pm

HTGC

Wells Fargo analyst Finian O'Shea maintains an Overweight rating on Hercules Capital (HTGC) and raises the price target from $19.5 to $20.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 6:01 pm

ZBH

Analyst ratings for Zimmer Biomet Holdings (NYSE:ZBH) have shown a diverse range from bullish to bearish over the last three months, with recent actions including both upgrades and downgrades. The average 12-month price target for ZBH has increased to $135.0, reflecting a 3.39% rise from the previous target. Zimmer Biomet, a leader in orthopedic reconstructive implants, has shown a revenue growth of 6.3% as of December 31, 2023, but its ROE is below industry standards. Despite this, its net margin and ROA outperform industry averages, and its debt-to-equity ratio is below the industry average, indicating strong financial health.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:01 pm

UDMY

Keybanc analyst Jason Celino has maintained an Overweight rating on Udemy (NASDAQ:UDMY) but lowered the price target from $15 to $14.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 6:01 pm

DKNG

Analyst ratings for DraftKings (NASDAQ:DKNG) show a mix of bullish to bearish sentiments, with recent actions mostly positive, raising price targets and maintaining high ratings. The average 12-month price target is now $53.3, up from $47.24, indicating a positive outlook. DraftKings has shown significant revenue growth and market expansion but faces challenges in profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:00 pm

HPP

Recent analyst ratings for Hudson Pacific Properties (NYSE:HPP) show a mix of somewhat bullish and indifferent sentiments, with 4 somewhat bullish and 3 indifferent ratings. The average 12-month price target is now $7.7, a 16.03% decrease from the previous $9.17 target. Analysts from firms like Piper Sandler and Morgan Stanley have adjusted their price targets and ratings, reflecting concerns over the company's financial performance, including a significant revenue decline of -17.23% and challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:00 pm

PATK

Patrick Industries (NASDAQ:PATK) received mixed analyst ratings, with a recent shift towards more bullish views. The average 12-month price target was raised to $122.5, reflecting an 11.03% increase from the previous target. The company faces challenges with a revenue decline of -17.94% and below-average net margin, but it has a strong ROE of 2.97%. Analysts from BMO Capital, Truist Securities, Keybanc, and Roth MKM have updated their ratings and price targets, indicating a positive outlook on the stock.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:00 pm